Skip to content

Periorbital Massage for Nausea and Vomiting After Laparoscopic Surgery

Effectiveness of Periorbital Massage in the Management of Nausea and Vomiting After Laparoscopic Cholecystectomy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06954935
Enrollment
2
Registered
2025-05-02
Start date
2025-04-23
Completion date
2025-09-10
Last updated
2025-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Cholecystectomy, Nausea, Vomiting

Keywords

nausea, voming, periorbital massage

Brief summary

Laparoscopic cholecystectomy is one of the commonly used surgical treatment methods for gallbladder diseases. However, many patients experience significant nausea and vomiting after laparoscopic cholecystectomy. It is observed that approximately 20% to 30% of patients experience postoperative nausea and vomiting as the most common complaint after laparoscopic cholecystectomy. This study aims to investigate the effectiveness of periorbital massage in postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.

Detailed description

This study aimed to investigate the effectiveness of periorbital massage in postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. One group received periorbital massage, while the other group did not receive massage.

Interventions

OTHERperiorbital massage

An electronic eye massager (irest manufacturing company, China) will be applied. The massager has a vibration function and massages with a warm air bag.

Sponsors

Atlas University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Those who have laparoscopic cholecystectomy surgery under general anesthesia, * Those between the ages of 18-70, * Those who do not have a psychiatric disease, * Those who understand what they read and volunteer patients, * Those who do not have a hearing or speech problem,

Exclusion criteria

* Patients undergoing emergency surgery, * Patients with psychiatric disorders * Patients who have taken another antiemetic drug within 24 hours before surgery

Design outcomes

Primary

MeasureTime frameDescription
Apfel risk scoreIt will be filled half an hour before you go down for surgery.: Apfel Risk Score is a simple scoring used to determine the risk status of patients for PONV. Apfel Risk Score questions four factors such as being female, not smoking, having a history of PONV/motion sickness and using postoperative opioids. Each factor is evaluated as 1 point. Apfel risk score varies between 0-4 and is classified as low, medium and high risk. Apfel Risk score 0-1 is evaluated as low risk, 2 as medium risk and 3-4 as high risk.
Numerical Scale of Nausea0, 2, 6, 12 and 24 hours after surgeryThe numerical scale of nausea is a scale that starts with 0 (no nausea) and ends with 10 (very severe nausea) and is given a numerical value with 1 cm intervals. The numerical scale is one-dimensional and is mainly used to evaluate the severity of pain.
Postoperative Nausea and Vomiting Impact Scale0, 2, 6, 12 and 24 hours after surgeryThere are four options in the two-question scale, each with 0, 1, 2, or 3 points. The first question asks whether there is vomiting or retching, if any, and the frequency; the answers are 0 no, 1 once, 2 twice, 3 three times or more, with four options. The second question asks whether there is nausea (feeling of discomfort in the stomach and feeling like vomiting), if any, whether the feeling of nausea affects your ability to get out of bed, move around comfortably in bed, walk normally, or your daily life activities such as eating and drinking; the answers are 0 not very often, 1 sometimes, 2 often or often, and 3 always, with four options. The numerical values of the answers given to the first and second questions are added up and the result is found.

Countries

Turkey (Türkiye)

Contacts

Primary Contactçağla toprak
cagla.toprak@atlas.edu.tr532 799 78 14

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026